← All trials
NCT04494958
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 18, 2020
- Primary completion
- Aug 1, 2023
- Completion date
- Aug 1, 2023
- First posted
- Jul 31, 2020
- Last posted
- Dec 17, 2020
- Enrollment
- 28
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Fundacion OncosurLead sponsor
- PfizerCollaborator
- Apices Soluciones S.L.Collaborator
- Centro Nacional de Investigaciones OncológicasOverall official - principal investigator
- Pierre FabreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.